HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical characteristics of four myositis-specific autoantibodies with regulatory-approved testing in Japan: A Japanese multi-centre adult myositis patients' cohort.

AuthorsIkuko Ueda-Hayakawa, Manabu Fujimoto, Shinji Sato, Akihiro Murakami, Atsushi Kawakami, Michiaki Mishima, Mariko Seishima, Takafumi Suda, Kazuhiko Takehara, Tsuneyo Mimori, Masataka Kuwana
JournalJournal of dermatological science (J Dermatol Sci) Vol. 103 Issue 1 Pg. 53-56 (Jul 2021) ISSN: 1873-569X [Electronic] Netherlands
PMID34088590 (Publication Type: Comparative Study, Letter, Multicenter Study, Observational Study)
Chemical References
  • Antigens, Ly
  • Autoantibodies
  • Biomarkers
  • CHD4 protein, human
  • SLURP1 protein, human
  • TRIM33 protein, human
  • Transcription Factors
  • Urokinase-Type Plasminogen Activator
  • Mi-2 Nucleosome Remodeling and Deacetylase Complex
  • IFIH1 protein, human
  • Interferon-Induced Helicase, IFIH1
Topics
  • Adult
  • Aged
  • Antigens, Ly (immunology)
  • Autoantibodies (blood, immunology, isolation & purification)
  • Biomarkers (blood)
  • Dermatomyositis (blood, diagnosis, immunology)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Interferon-Induced Helicase, IFIH1 (immunology)
  • Japan
  • Male
  • Mi-2 Nucleosome Remodeling and Deacetylase Complex (immunology)
  • Middle Aged
  • Retrospective Studies
  • Severity of Illness Index
  • Transcription Factors (immunology)
  • Urokinase-Type Plasminogen Activator (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: